What is the market doing?
What the tape says about AZN
AstraZeneca PLC is +13% over the past year while the S&P 500 is +23%: 9.1 points behind the market.
+13%
1-year return · S&P 500 +23%
- vs 200-day average
- −8.8%
vs 200-day average · below trend, but not far
- RSI (14)
- 61
RSI (14) · neutral
- Below its 52-week high
- −20%
Below its 52-week high
Details›
- Last close2026-08-26
- $166.29
- 1 monthS&P 500 +3.7%
- −1.2%
- 1 yearS&P 500 +23%
- +13%
- 5 yearsS&P 500 +87%
- +61%
- vs 50-day average$170.54
- −2.5%
- 52-week high
- $208.62
- 52-week low
- $145.54
- Annualised volatility
- 26%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$2.2M
| Year | Return |
|---|---|
| 2026 (year to date) | −8.6% |
| 2025 | +43% |
| 2024 | −0.62% |
| 2023 | +1.4% |
| 2022 | +19% |
| 2021 | +20% |
| 2020 | +3.1% |
| 2019 | +36% |
| 2018 | +14% |
| 2017 | +33% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | +0.01% |
| Feb | 10 | 6 of 10 | +4.2% |
| Mar | 10 | 7 of 10 | +2.6% |
| Apr | 10 | 6 of 10 | +2.6% |
| May | 10 | 7 of 10 | +3.2% |
| Jun | 10 | 3 of 10 | −0.00% |
| Jul | 11 | 8 of 11 | +1.7% |
| Aug | 11 | 6 of 11 | +1.2% |
| Sep | 10 | 4 of 10 | −1.0% |
| Oct | 10 | 5 of 10 | −0.92% |
| Nov | 10 | 5 of 10 | +0.79% |
| Dec | 10 | 5 of 10 | +0.90% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - General
Ranks #3 of 16 by Smart Score